Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization-Reference-Cited by-同舟云学术

Orally disintegrating tablet containing carbamazepine and levetiracetam: formulation and in vitro and in vivo characterization

Published:2021-07-03 Issue:7 Volume:47 Page:1153-1165
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Kandilli Busra¹,Ugur Kaplan Afife Busra¹,Cetin Meltem¹^ORCID,Taspınar Numan²,Genc Sidika³,Yeni Yesim³,Ertugrul Muhammed Sait³⁴,Aydin Ismail Cagri³,Hacimuftuoglu Ahmet³

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey

2. Department of Medical Pharmacology, Faculty of Medicine, Usak University, Usak, Turkey

3. Department of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Turkey

4. Department of Pharmacology, Faculty of Pharmacy, Agri Ibrahim Cecen University, Agri, Turkey

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2021.1988094

Reference65 articles.

1. Development and evaluation of carbamazepine fast dissolving tablets prepared with a complex by direct compression technique

2. Solid Oral Flexible Formulations for Pediatric and Geriatric patients: Age-appropriate Formulation Platforms

3. Suñé Neģre JM, Roiģ Carreras M, García RF, et al. Chapter 5: SeDeM diagram: an expert system for preformation, characterization and optimization of tablets obtained by direct compression. In: Aguilar JE, editor. Formulation tools for pharmaceutical development. Cambridge: Woodhead Publishing; 2013. p. 109–135.

4. The new definition and classification of seizures and epilepsy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation and development of paediatric orally disintegrating carbamazepine tablets;Saudi Pharmaceutical Journal;2022-11

2. Development and optimization of orally disintegrating tablets containing Centella asiatica solid lipid nanoparticles for supportive therapies of Parkinson's disease;F1000Research;2022-05-13